Luxist Web Search

Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authorityrecognized by the World Health Organization(WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi–GSK.[1]

The National COVID-19 Immunisation Programme ( Malay: Program Imunisasi COVID-19 Kebangsaan ), abbreviated as NIP or PICK, is a national vaccination campaign that is currently being implemented by the Malaysian government as an approach in curbing the spread of coronavirus disease 2019 (COVID-19) and to end the COVID-19 pandemic in Malaysia by …

The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. [1] In terms of total doses given, Indonesia ranks third in Asia and fifth in the world. [2]

(Top) 1Background 2Vaccine technologies Toggle Vaccine technologies subsection 2.1mRNA vaccines 2.2Adenovirus vector vaccines 2.3Inactivated virus vaccines 2.4Subunit vaccines 2.5Other types 3List of authorized vaccines 4Delivery methods Toggle Delivery methods subsection 4.1Intranasal 4.2Autologous 5Universal vaccine 6Formulation

A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date (s) one has received the shot (s) and the brand of vaccine one has received, sometimes including the lot number. The card also contains information identifying the recipient and the location where the shot was given.

t. e. Sputnik V ( Russian: Спутник V, the brand name from RDIF) or Gam-COVID-Vac ( Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced [3]) is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. It is the world's ...